Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Unknown 4Completed 3Withdrawn 1

Sponsor Class

NIH 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Breast Neoplasms 19Rectal Neoplasms 11Colorectal Neoplasms 11Colonic Neoplasms 11Central Nervous System Neoplasms 8Stomach Neoplasms 7Carcinoma, Non-Small-Cell Lung 6Neoplasm Metastasis 5Melanoma 5Lung Neoplasms 4Liver Neoplasms 4Kidney Neoplasms 4Carcinoma, Hepatocellular 4Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Recurrence 2Prostatic Neoplasms 2Ovarian Neoplasms 2Neuroblastoma 2Lymphatic Metastasis 2Glioblastoma 2Breast Neoplasms, Male 2Astrocytoma 2Wilms Tumor 1Uveal Melanoma 1Uterine Cervical Neoplasms 1

Interventions

Sorafenib 9Radiofrequency Ablation 7Oxaliplatin 7Fluorouracil 6Doxorubicin 6Neoadjuvant Therapy 5toripalimab 4lenvatinib 4Injections 4Chemotherapy, Adjuvant 4Bevacizumab 4sintilimab 3pembrolizumab 3Ultrasonography 3Thalidomide 3Leucovorin 3Irinotecan 3Cisplatin 3tislelizumab 2durvalumab 2camrelizumab 2anlotinib 2Walking Speed 2Standard of Care 2Radiosurgery 2Oncolytic Virotherapy 2Metformin 2Liver Transplantation 2Laparoscopy 2Immunohistochemistry 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Liver Neoplasms × Chemotherapy, Adjuvant × Clear all
NCT00077389 2014-06-24

Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma

National Cancer Institute (NCI)

Phase 2 Unknown
57 enrolled
Gastrointestinal

Liver Neoplasms, Hepatoblastoma

NCT00027768 2013-09-20

Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00276705 2013-09-17

Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
47 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00471484 2011-06-22

Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Unknown
54 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡